Update information

Update information

Minor changes since publication

January 2019: Contact details for the patient access scheme for colistimethate sodium DPI (Colobreathe) updated because Colobreathe is now owned by Teva UK.

June 2013: Implementation note deleted from the start of section 1 because colistimethate sodium dry powder for inhalation is now available in the UK.

ISBN: 978-1-4731-3288-7

  • National Institute for Health and Care Excellence (NICE)